BIOSECURE Act (Dec 2025, FY26 NDAA)
eventBiotech & Transhumanism
The U.S. just moved to cut Chinese biotech firms out of its genetic supply chain — a sign the world's DNA trade is splitting along national lines.
Who they are
The BIOSECURE Act, signed into law December 18, 2025 as part of the annual defense bill (Section 851).
What they do
It blocks the federal government from buying from 'biotechnology companies of concern.'
How it works
It works through the Defense Department's '1260H' list, a mechanism that reaches Chinese firms like BGI and MGI — though the law itself names no company directly, leaving those designations pending. Its sourcing is Politico and law-firm advisories.
Why it matters
The engine reads it as the genome trade fracturing into a state-versus-state contest — evidence that a global, cooperative DNA market is giving way to national walls.
The engine's record — word for word
**In plain terms:** the US move to wall off genomic supply chains. Signed Dec 18 2025 (FY26 NDAA, §851); bars federal procurement from 'biotechnology companies of concern' via the DoD 1260H list (mechanism that reaches BGI/MGI; the statute names none directly — designation pending OMB). Marks the militarization/balkanization of the genome trade — a state-vs-state fracture (Royal Cousin: Claim A dead). Source: P3; POLITICO; law-firm advisories.
Follow the trail
Walk this on the live map →